Erin N. Kobetz, Ph.D., M.P.H., has been named Senior Associate Dean for Health Disparity at the University of Miami Miller School of Medicine. In this role Kobetz will be responsible for elevating the awareness of current regional health disparities while developing a culture in which UHealth – University of Miami Health System and the Miller School can achieve health equity for patients.
News : 2015
The University of Miami Hospital and Clinics welcomed all 189 third-year Miller School students from both the Miami and regional medical campuses June 6-7 for the 20th annual Objective Structured Clinical Examinations, a medical school rite of passage that tests the clinical skills of students. More than 100 faculty members served as evaluators for the annual assessment.
Six Miller School of Medicine physician-scientists were recognized for their contributions to cancer research and treatment as part of the Sylvester Comprehensive Cancer Center’s 16th Annual Zubrod Memorial Lecture and Cancer Research Poster Session on May 15. It was the first time multiple faculty awards have been part of the program.
For Miller School medical students and teachers, the 2015 George Paff Teaching Awards Ceremony was a warm and memorable experience, punctuated by tears of joy, plenty of hugs and a baby’s cry.
Deans, faculty and students representing the Miller School of Medicine’s regional medical campus gathered on April 8 for the second annual Regional Campus Paff Awards Ceremony. The event, which was organized and hosted by the regional campus student government, recognizes faculty members and residents contributing to the education of students in the dual-degree M.D./M.P.H. program.
In a single week last August in New York City, two first-year residents, in different programs and in separate incidents, jumped to their deaths. What could have happened, just three months after their triumphant graduation from medical school, that would have made them want to take their lives? We may never know, but a likely contributing factor is a syndrome called burnout.
Researchers seeking to improve treatment outcomes for women with recurrent endometrial cancer – the most commonly diagnosed gynecologic malignancy in the U.S., killing more than 8,000 women each year – have reported positive results through targeted therapy that uses a combination of the drugs everolimus and letrozole. Their findings have been reported in the Journal of Clinical Oncology.